Spinal Muscular Atrophy Trial, Recruiting NCT06577350 Sponsor: Ankara University Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT06577350
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with a spine condition:

  • You have been diagnosed with Ankylosing Spondylitis or a related spine condition called non-radiographic Spondyloarthritis, confirmed using standard medical criteria
  • You are between 18 and 65 years old
  • You are willing to give your consent to take part in the study

For healthy volunteers:

  • You are a healthy person between 18 and 65 years old who can be matched by age and gender to a patient participant
  • You are willing to give your consent to take part in the study

Who may not be able to join:

  • You have been taking high-dose steroid medication (more than 5mg of prednisone per day for more than 3 months)
  • You have certain other health conditions that can cause muscle loss, such as uncontrolled diabetes, chronic heart failure, thyroid or parathyroid disease, chronic kidney failure, or chronic liver failure
  • You have a hand condition or injury that would affect your ability to have your grip strength measured accurately
  • You are taking certain medications that can affect bone health, such as bisphosphonates, teriparatide, anticonvulsants, heparin, or blood thinners
  • You have psoriasis or inflammatory bowel disease
  • You have an active infection in the thigh area where an ultrasound scan would be carried out
  • You weigh more than 100 kg, as this affects the bone density scanning equipment used in the study
  • You are assessed as malnourished based on a short nutrition screening questionnaire (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ayşe A Küçükdeveci, MD, Ankara University, Medical Faculty

Phone: +90 312 5082850

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara University
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
1 January 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Presence of osteosarcopenia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov